Alfalah Welfare Organization is promoting awareness in the community to become blood donors to save lives. For this purpose, we continue running awareness sessions, workshops, and seminars with the help of volunteer doctors and health esports. We are also arranging free blood group test camps to raise people’s awareness of their blood group. We are organizing free blood sugar and Hepatitis C testing camps in the area from time to time.   

Human immunodeficiency virus (HIV)

Human immunodeficiency virus (HIV) infection has further complicated control and prevention since the advent of the HIV epidemic. The global epidemiology of TB-HIV co-infection is still emerging since there are few systematic surveillance systems. However, modeling studies still indicate that the proportion of cases of TB who are coinfected has been increasing in many parts of the world. India, Indonesia, and China account for 33% of global TB cases. In these countries, poverty, HIV infection, lack of access to health care, and over-reliance on ineffective and economically irresponsible services make controlling the TB epidemic, both drug-susceptible and drug-resistant, a daunting challenge.

Control of the TB

Control of the TB epidemic globally, particularly in these countries, is further hindered by malnutrition, crowded and substandard conditions, occupational exposure such as in mining, and environmental factors, including air pollution. Strikingly, research has failed to obtain strong associations between TB incidence in either urban or rural districts and reported hospital prevalence (from blood culture surveys) of vitamin and nutrient deficiencies or HIV prevalence, which further supports the notion that there is a missing key Environmental Reservoir of Infection in these settings.

Leading cause of death worldwide

Tuberculosis (TB) remains the leading cause of death worldwide from an infectious disease in humans. It is estimated by the World Health Organization (WHO) that about a third of the world’s population is infected with Mycobacterium tuberculosis, with 8-10 million new cases of active TB every year leading to 1.5 million deaths annually.

TB Treatment

Among the known TB patients, the vast majority will be successfully treated after either short- or long-term chemotherapy in a directly observed therapy, short-course (DOTS) program. However, treatment fails in 10% of cases due to drug resistance or poor patient adherence to chemotherapy. Under these circumstances, patients with pulmonary TB can infect family members, friends, and other close contacts. MDR-TB, in turn, can lead to the development of XDR-TB, rendering patients untreatable by most known anti-TB drugs.

How to participate to prevent TB?

There are several programs are running under NGO’s hat you can participate. Majority of the patients can’t afford treatment expenses. We encourage you to donate through charity or Zakat. To calculate your zakat, you can use our online Zakat Calculator.